Tissue-mimicking phantoms for performance evaluation of photoacoustic microscopy systems

Journal Article · Mon Feb 07 00:00:00 EST 2022 · Biomedical Optics Express

DOI:https://doi.org/10.1364/BOE.445702· OSTI ID:1843860

Hsu, Hsun-Chia; Wear, Keith A.; Joshua Pfefer, T. ; Vogt, William C.

Phantom-based performance test methods are critically needed to support development and clinical translation of emerging photoacoustic microscopy (PAM) devices. While phantoms have been recently developed for macroscopic photoacoustic imaging systems, there is an unmet need for well-characterized tissue-mimicking materials (TMMs) and phantoms suitable for evaluating PAM systems. Our objective was to develop and characterize a suitable dermis-mimicking TMM based on polyacrylamide hydrogels and demonstrate its utility for constructing image quality phantoms. TMM formulations were optically characterized over 400–1100 nm using integrating sphere spectrophotometry and acoustically characterized using a pulse through-transmission method over 8–24 MHz with highly confident extrapolation throughout the usable band of the PAM system. This TMM was used to construct a spatial resolution phantom containing gold nanoparticle point targets and a penetration depth phantom containing slanted tungsten filaments and blood-filled tubes. These phantoms were used to characterize performance of a custom-built PAM system. The TMM was found to be broadly tunable and specific formulations were identified to mimic human dermis at an optical wavelength of 570 nm and acoustic frequencies of 10–50 MHz. Imaging results showed that tungsten filaments yielded 1.1–4.2 times greater apparent maximum imaging depth than blood-filled tubes, which may overestimate real-world performance for vascular imaging applications. Nanoparticles were detectable only to depths of 120–200 µm, which may be due to the relatively weaker absorption of single nanoparticles vs. larger targets containing high concentration of hemoglobin. The developed TMMs and phantoms are useful tools to support PAM device characterization and optimization, streamline regulatory decision-making, and accelerate clinical translation.

• Sponsoring Organization: USDOE
• OSTI ID: 1843860
• Journal Information: Biomedical Optics Express, Journal Name: Biomedical Optics Express Vol. 13 Journal Issue: 3; ISSN 2156-7085
• Publisher: Optical Society of America
• Country of Publication: United States
• Language: English